Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 39 matching records.
39 results — page 1 of 2
- Level DAnimal StudyPubMed
Targeting senescent cells in aged adipose tissue induced by ovarian cancer with the NF-κB inhibitor quercetin and resveratrol impedes the growth and metastasis of ovarian cancer.
Animal Study on Type 2 Diabetes, published in Sci China Life Sci (2026) — summary generated from the PubMed abstract.
- 2026
Sci China Life Sci - Level DNarrative ReviewEurope PMC
Targeting Epicardial/Pericardial Adipose Tissue in Cardiovascular Diseases: A Novel Therapeutic Strategy
Narrative Review on Cardiovascular Disease, published in Rev Cardiovasc Med (2025) — summary generated from the PubMed abstract.
- 2025
Rev Cardiovasc Med2 citations - Level DAnimal StudyEurope PMC
Targeting IRE1α improves insulin sensitivity and thermogenesis and suppresses metabolically active adipose tissue macrophages in male obese mice
Animal Study on Type 2 Diabetes, published in Elife (2025) — summary generated from the PubMed abstract.
- 2025
Elife5 citations - Level DNarrative ReviewPubMed
Targeting Muscle Regeneration with Small Extracellular Vesicles from Adipose Tissue-Derived Stem Cells-A Review.
Narrative Review on Tendon Injury, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells4 citations - Level DAnimal StudyPubMed
Combined pharmacological targeting of CD9 + progenitors alleviates obesity-induced adipose tissue fibrosis and metabolic impairment.
Animal Study on Type 2 Diabetes, published in Cell Rep Med (2025) — summary generated from the PubMed abstract.
- 2025
Cell Rep Med - Level DAnimal StudyPubMed
Adipocyte cell therapy targeting BMP signaling alleviates fibroadipose tissue deposition in secondary lymphedema.
Animal Study on Systemic / IV, published in Mol Ther (2025) — summary generated from the PubMed abstract.
- 2025
Mol Ther - Level DAnimal StudyEurope PMC
Nanomedicine targeting PPAR in adipose tissue macrophages improves lipid metabolism and obesity-induced metabolic dysfunction
Animal Study on Systemic / IV, published in Sci Adv (2025) — summary generated from the PubMed abstract.
- 2025
Sci Adv3 citations - Level DNarrative ReviewEurope PMC
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia
Narrative Review on Hip, published in Aging Dis (2024) — summary generated from the PubMed abstract.
- 2024
Aging Dis13 citations - Level DNarrative ReviewEurope PMC
Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities
Narrative Review on Type 2 Diabetes, published in MedComm (2020) (2024) — summary generated from the PubMed abstract.
- 2024
MedComm (2020)18 citations - Level DAnimal StudyPubMed
Icariside II protects from marrow adipose tissue (MAT) expansion in estrogen-deficient mice by targeting S100A16.
Animal Study, published in J Mol Endocrinol (2024) — summary generated from the PubMed abstract.
- 2024
J Mol Endocrinol - Level DNarrative ReviewEurope PMC
Directly targeting PRDM16 in thermogenic adipose tissue to treat obesity and its related metabolic diseases
Narrative Review on Systemic / IV, published in Front Endocrinol (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Endocrinol (Lausanne)14 citations - Level DAnimal StudyPubMed
Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.
Animal Study, published in Bioeng Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
Bioeng Transl Med - Level DAnimal StudyPubMed
Increased serum extracellular vesicle miR-144-3p and miR-486a-3p in a mouse model of adipose tissue regeneration promote hepatocyte proliferation by targeting Txnip.
Animal Study, published in PLoS One (2023) — summary generated from the PubMed abstract.
- 2023
PLoS One6 citations - Level DAnimal StudyEurope PMC
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
Animal Study with a reported sample of 42 on Chronic Inflammation, published in JHEP Rep (2023) — summary generated from the PubMed abstract.
- 2023
- n = 42
JHEP Rep15 citations - Level DAnimal StudyEurope PMC
Targeting p21 Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity
Animal Study on Type 2 Diabetes, published in Cell Metab (2022) — summary generated from the PubMed abstract.
- 2022
Cell Metab136 citations - Level DAnimal StudyPubMed
Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury.
Animal Study on Cardiovascular Disease, published in Free Radic Biol Med (2022) — summary generated from the PubMed abstract.
- 2022
Free Radic Biol Med - Level DNarrative ReviewPubMed
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy.
Narrative Review, published in Biomolecules (2022) — summary generated from the PubMed abstract.
- 2022
Biomolecules12 citations - Level DAnimal StudyEurope PMC
Divergence of Chemerin Reduction by an ATS9R Nanoparticle Targeting Adipose Tissue In Vitro vs. In Vivo in the Rat
Animal Study, published in Biomedicines (2022) — summary generated from the PubMed abstract.
- 2022
Biomedicines3 citations - Level DLaboratory StudyEurope PMC
Fatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis
Laboratory Study on Type 2 Diabetes, published in Adv Sci (Weinh) (2022) — summary generated from the PubMed abstract.
- 2022
Adv Sci (Weinh)22 citations - Level DAnimal StudyEurope PMC
Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages
Animal Study on Type 2 Diabetes, Chronic Inflammation, published in Nat Commun (2021) — summary generated from the PubMed abstract.
- 2021
Nat Commun85 citations - Level DNarrative ReviewPubMed
Targeting intramuscular adipose tissue expansion to preserve contractile function in volumetric muscle loss: A potentially novel therapy?
Narrative Review, published in Curr Opin Pharmacol (2021) — summary generated from the PubMed abstract.
- 2021
Curr Opin Pharmacol - Level CProspective StudyEurope PMC
Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4
Prospective Study on Systemic / IV, published in Adipocyte (2020) — summary generated from the PubMed abstract.
- 2020
Adipocyte29 citations - Level DNarrative ReviewEurope PMC
Perivascular Adipose Tissue Regulates Vascular Function by Targeting Vascular Smooth Muscle Cells
Narrative Review, published in Arterioscler Thromb Vasc Biol (2020) — summary generated from the PubMed abstract.
- 2020
Arterioscler Thromb Vasc Biol127 citations - Level DLaboratory StudyPubMed
miR-23a-3p regulated by LncRNA SNHG5 suppresses the chondrogenic differentiation of human adipose-derived stem cells via targeting SOX6/SOX5.
Laboratory Study, published in Cell Tissue Res (2020) — summary generated from the PubMed abstract.
- 2020
Cell Tissue Res13 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406